NCT03735238Completed
Implementing the Decision-Aid for Lupus (IDEAL Strategy)
Source: ClinicalTrials.gov · Last updated 10 Oct 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
The study will attempt to put into practice a shared decision making (SDM) strategy, using an individualized, computerized decision- aid (DA) for Systemic lupus erythematosus (SLE).
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 1895 (actual)
- First submitted
- 31 Oct 2018
- Start date
- 15 Dec 2018
- Primary completion date
- 15 Nov 2024
- Lead sponsor
- University of Alabama at Birmingham
- Diseases
- Lupus (SLE)
- NCT number
- NCT03735238
What you commit to
- Study type: Observational
- Participants enrolled: 1895
- From 15 Dec 2018 to the primary completion date, 15 Nov 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Criteria the registry did not label
- Patient Inclusion Criteria:
- Adults with a diagnosis of Systemic Lupus Erythematosus (SLE) by a rheumatologist
- Patient Exclusion Criteria:
- No diagnosis of lupus, not English or Spanish speaking, visually impaired, altered mental status
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University of Alabama at Birmingham Coordinator of this site? Confirm its status | Birmingham | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.